EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids

Darshini Desai, Taejeong Song, Rohit R Singh, Akhil Baby iD, James McNamara iD, Lisa C Green, Pooneh Nabavizadeh, Mark Ericksen, Sholeh Bazrafshan, Sankar Natesan, Sakthivel Sadayappan

Cells · 2024

DOI: 10.3390/cells13221913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Darshini Desai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Research, Division of Cardiovascular Health and Disease, Department of Internal Medicine, University of Cincinnati College …. Hauptthemen laut MEDLINE: Carrier Proteins, Induced Pluripotent Stem Cells, Organoids, Myocytes, Cardiac. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MYBPC3, encoding cardiac myosin binding protein-C (cMyBP-C), is the most mutated gene known to cause hypertrophic cardiomyopathy (HCM). However, since little is known about the underlying etiology, additional in vitro studies are crucial to defining the underlying molecular mechanisms. Accordingly, this study aimed to investigate the molecular mechanisms underlying the pathogenesis of HCM associated with a polymorphic variant (D389V) in MYBPC3 by using isogenic human-induced pluripotent stem cell (hiPSC)-derived cardiac organoids (hCOs). The hiPSC-derived cardiomyocytes (hiPSC-CMs) and hCOs were generated from human subjects to define the molecular, cellular, functional, and energetic changes caused by the MYBPC3D389V variant, which is associated with increased fractional shortening and highly prevalent in South Asian descendants. Recombinant C0-C2, N’ region of cMyBP-C (wild-type and D389V), and myosin S2 proteins were also utilized to perform binding and motility assays in vitro. Confocal and electron microscopic analyses of hCOs generated from noncarriers (NC) and carriers of the MYBPC3D389V variant revealed the presence of highly organized sarcomeres. Furthermore, functional experiments showed hypercontractility, faster calcium cycling, and faster contractile kinetics in hCOs expressing MYBPC3D389V than NC hCOs. Interestingly, significantly increased cMyBP-C phosphorylation in MYBPC3D389V hCOs was observed, but without changes in total protein levels, in addition to higher oxidative stress and lower mitochondrial membrane potential (ΔΨm). Next, spatial mapping revealed the presence of endothelial cells, fibroblasts, macrophages, immune cells, and cardiomyocytes in the hCOs. The hypercontractile function was significantly improved after the treatment of the myosin inhibitor mavacamten (CAMZYOS®) in MYBPC3D389V hCOs. Lastly, various vitro binding assays revealed a significant loss of affinity in the presence of MYBPC3D389V with myosin S2 region as a likely mechanism for hypercontraction. Conceptually, we showed the feasibility of assessing the functional and molecular mechanisms of HCM using highly translatable hCOs through pragmatic experiments that led to determining the MYBPC3D389V hypercontractile phenotype, which was rescued by the administration of a myosin inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carrier ProteinsInduced Pluripotent Stem CellsOrganoidsMyocytes, CardiacHumansMyocardial ContractionCardiomyopathy, HypertrophicCalciumSarcomeresMyocardiumMyosin Binding Protein C

Stichwörter der Autor:innen

MYBPC3cardiac organoidshypercontractionhypertrophic cardiomyopathymavacamten

Substanzen

Carrier ProteinsCalciumMyosin Binding Protein C

Autor:innen und Institutionen

  • Center for Cardiovascular Research, Division of Cardiovascular Health and Disease, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
  • Department of Genetic Engineering, School of Biotechnology, Madurai Kamaraj University, Madurai 625021, India.

ORCID-Profile: Akhil Baby, James McNamara

Förderung

  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • American Heart Association
  • National Institutes of Health
  • the American Heart Association, Institutional Undergraduate Student

Zitieren

APA

Desai, D., Song, T., Singh, R. R., Baby, A., McNamara, J., Green, L. C., Nabavizadeh, P., Ericksen, M., Bazrafshan, S., Natesan, S., & Sadayappan, S. (2024). MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids. Cells. https://doi.org/10.3390/cells13221913

Vancouver

Desai D, Song T, Singh RR, Baby A, McNamara J, Green LC, et al. MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids. Cells. 2024. doi:10.3390/cells13221913

BibTeX
@article{Desai2024,
  author = {Desai, Darshini and Song, Taejeong and Singh, Rohit R and Baby, Akhil and McNamara, James and Green, Lisa C and Nabavizadeh, Pooneh and Ericksen, Mark and Bazrafshan, Sholeh and Natesan, Sankar and Sadayappan, Sakthivel},
  title = {MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13221913}
}
Kostenlos starten →